Understanding the pharmacokinetics and toxicokinetics of target compounds is important in drug development. BRT offers a suite of immunopharmacology tests – both In Vivo and In Vitro – to evaluate the pharmacological properties of therapeutic products in preclinical studies.

Our immunopharmacology services help measure the distribution and elimination of test compounds, identify potential mechanisms of action, evaluate dose-response relationships, and assess overall efficacy.